Gastroesophageal Junction Adenocarcinoma
Showing NaN - NaN of 7
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- tucatinib
- +5 more
-
Birmingham, Alabama
- +47 more
Oct 27, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +27 more
- Carboplatin
- +4 more
-
Anchorage, Alaska
- +469 more
Aug 24, 2022
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas
Recruiting
- Esophagus Adenocarcinoma
- +2 more
-
Dallas, TexasDallas VA Medical Center
Nov 2, 2021
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)
Active, not recruiting
- Metastatic Cancer
- +4 more
- VE800
- +2 more
-
Scottsdale, Arizona
- +17 more
Jun 22, 2021
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Georgia, United States
Unknown status
- Gastric Adenocarcinoma
- +2 more
-
Dallas, Texas
- +4 more
Nov 28, 2014